![Albert W. Gianchetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert W. Gianchetti
Chief Executive Officer at
Nuevocor Pte Ltd.
Profile
Albert W.
Gianchetti is Chief Executive Officer & Director at Nuevocor Pte Ltd. since 2026.
Former roles include President, Chief Executive Officer & Director at Xylocor Therapeutics, Inc., Chief Commercial Officer & Senior Vice President at Vanda Pharmaceuticals, Inc. from 2007 to 2008, and Vice President-Global Commercial Strategy at GSK Plc.
Education includes an MBA from Drexel University and an undergraduate degree from the University of Delaware.
Albert W. Gianchetti active positions
| Companies | Position | Start |
|---|---|---|
Nuevocor Pte Ltd.
 Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapy for cardiac diseases | Chief Executive Officer | 2026-01-07 |
Former positions of Albert W. Gianchetti
| Companies | Position | End |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2008-11-30 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Chief Executive Officer | - |
| GSK PLC | Corporate Officer/Principal | - |
Training of Albert W. Gianchetti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Nuevocor Pte Ltd.
Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapy for cardiac diseases | Health Technology |
- Stock Market
- Insiders
- Albert W. Gianchetti
